Loading...
Loading...
India's atorvastatin imports from PHILIPPINES total $616 across 1 shipments from 1 foreign suppliers. TORRENT PHARMA PHILIPPINES INC. leads with $616 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include TORRENT PHARMACEUTICALS LTD. This corridor reflects India's pharmaceutical import demand for atorvastatin — a concentrated sourcing relationship with select suppliers from PHILIPPINES.

TORRENT PHARMA PHILIPPINES INC. is the leading Atorvastatin supplier from PHILIPPINES to India, with import value of $616 across 1 shipments. The top 5 suppliers — TORRENT PHARMA PHILIPPINES INC. — collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | TORRENT PHARMA PHILIPPINES INC. | $616 | 1 | 100.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | TORRENT PHARMACEUTICALS LTD | $616 | 1 | 100.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Atorvastatin suppliers from PHILIPPINES to India include TORRENT PHARMA PHILIPPINES INC.. The leading supplier is TORRENT PHARMA PHILIPPINES INC. with import value of $616 USD across 1 shipments. India imported Atorvastatin worth $616 USD from PHILIPPINES in total across 1 shipments.
India imported Atorvastatin worth $616 USD from PHILIPPINES across 1 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Atorvastatin sourced from PHILIPPINES include TORRENT PHARMACEUTICALS LTD. The largest buyer is TORRENT PHARMACEUTICALS LTD with $616 in imports across 1 shipments.
The total value of Atorvastatin imports from PHILIPPINES to India is $616 USD, across 1 shipments and 1 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1 Verified Shipments
1 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists